CapsoVision vs Profound Medical
Profound Medical reported revenue of $16 million in fiscal 2025, 1.2 times CapsoVision's $14 million in fiscal 2025. CapsoVision's revenue grew 15.3% in its latest year, and Profound Medical's grew 50.7%. CapsoVision had an operating margin of -188.2%, against -256.3% at Profound Medical. Free cash flow was −$23 million at CapsoVision and −$38 million at Profound Medical.
Side by side
| CapsoVision | Profound Medical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $14M | $16M |
| Revenue growth | 15.3% | 50.7% |
| Revenue growth a year, last 5 years | — | 17.1% |
| Gross margin | 52.9% | 70.8% |
| Operating margin | −188.2% | −256.3% |
| Net margin | −186.8% | −264.4% |
| Free cash flow | −$23M | −$38M |
| Free cash flow margin | −169.3% | −238.4% |
| Return on capital | — | −304.9% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 1,115.6% | 22.1% |
| Last close | $6.31 | $6.59 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $16.0 million, sold $0 | — |
| Piotroski F-score | — | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CapsoVisionProfound Medical
Operating margin
Percent of revenue
CapsoVisionProfound Medical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CapsoVisionProfound Medical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CapsoVision and Profound Medical pages.